HCW Biologics (HCWB) News Today $0.65 +0.05 (+8.35%) (As of 07/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 November 2021 October 2021 September 2021 August 2021 Time Period May 15, 2024 | investorplace.comHCWB Stock Earnings: HCW Biologics Reported Results for Q1 2024May 15, 2024 | marketwatch.comHCW Biologics Warns of Ability to Continue Operating Without Additional FundsMay 15, 2024 | markets.businessinsider.comHCW Biologics Reports First Quarter 2024 Financial Results and Business HighlightsMay 15, 2024 | globenewswire.comHCW Biologics Reports First Quarter 2024 Financial Results and Business HighlightsApril 2, 2024 | marketbeat.comHCW Biologics Inc. (NASDAQ:HCWB) Short Interest UpdateHCW Biologics Inc. (NASDAQ:HCWB - Get Free Report) was the target of a large drop in short interest in March. As of March 15th, there was short interest totalling 22,000 shares, a drop of 8.3% from the February 29th total of 24,000 shares. Based on an average daily volume of 16,700 shares, the days-to-cover ratio is presently 1.3 days. Currently, 0.1% of the company's stock are short sold.April 2, 2024 | investorplace.comHCWB Stock Earnings: HCW Biologics Misses EPS, Misses Revenue for Q4 2023April 1, 2024 | globenewswire.comHCW Biologics Reports Fourth Quarter 2023 and Fiscal Year End Financial Results And Business HighlightsMarch 12, 2024 | marketbeat.comHCW Biologics Inc. (NASDAQ:HCWB) Sees Large Growth in Short InterestHCW Biologics Inc. (NASDAQ:HCWB - Get Free Report) was the recipient of a large increase in short interest during the month of February. As of February 29th, there was short interest totalling 24,000 shares, an increase of 445.5% from the February 14th total of 4,400 shares. Based on an average daily volume of 14,500 shares, the short-interest ratio is presently 1.7 days. Currently, 0.2% of the company's stock are sold short.February 24, 2024 | finance.yahoo.comRebecca Byam Bought 122% More Shares In HCW BiologicsJanuary 25, 2024 | finance.yahoo.comSeveral Insiders Invested In HCW Biologics Flagging Positive NewsNovember 17, 2023 | markets.businessinsider.comHCW Biologics Receives Buy Rating: Strong Financial Position and Promising Clinical Data Validate Investment OpportunityNovember 15, 2023 | markets.businessinsider.comAnalysts Are Bullish on Top Healthcare Stocks: HCW Biologics (HCWB), Urogen Pharma (URGN)November 14, 2023 | finanznachrichten.deHCW Biologics, Inc: HCW Biologics Reports Third Quarter 2023 Financial Results And Recent Business HighlightsNovember 14, 2023 | msn.comHCW Biologics GAAP EPS of -$0.14, revenue of $174.77MNovember 14, 2023 | finance.yahoo.comHCW Biologics Reports Third Quarter 2023 Financial Results And Recent Business HighlightsNovember 11, 2023 | morningstar.comADMA Biologics Inc ADMANovember 11, 2023 | morningstar.comHCW Biologics Inc HCWBNovember 11, 2023 | markets.businessinsider.comPromising Phase 1 Results and Potential Synergies with PD-1 Inhibitors Bolster Buy Rating for HCW BiologicsNovember 8, 2023 | finance.yahoo.comInvestigator Sponsor of HCW Biologics’ Phase 1 Clinical Trial Presented Human Data Readout and Anti-Cancer Mechanism of Action of HCW9218 at 38th SITC Annual MeetingNovember 6, 2023 | finance.yahoo.comSamsung Biologics and Kurma Partners announce strategic partnership for development and manufacturing of biologics for Kurma's portfolio companiesNovember 1, 2023 | finance.yahoo.comMasonic Cancer Center, University of Minnesota to Present Data in Poster Presentation Human Data Readout for Phase 1 Study to Evaluate HCW9218 in Solid Tumors at SITC 38th Annual MeetingSeptember 21, 2023 | seekingalpha.comHCW Biologics director Gary Winer buys shares worth $3.3k - filingSeptember 16, 2023 | finance.yahoo.comInsider Buying: CFO Rebecca Byam Acquires 5,000 Shares of HCW Biologics IncSeptember 9, 2023 | finance.yahoo.comInsider Buying: CFO Rebecca Byam Acquires 10,000 Shares of HCW Biologics IncSeptember 6, 2023 | finance.yahoo.comHCW Biologics Participating at H.C. Wainwright 25th Annual Global Investment Conference in New York on September 11 – 13, 2023August 18, 2023 | finance.yahoo.comInsider Stock Buying Reaches US$845k On HCW BiologicsAugust 15, 2023 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: HCW Biologics (HCWB) and Cochlear Limited (OtherCHEOF)August 11, 2023 | finanznachrichten.deHCW Biologics, Inc: HCW Biologics Reports Second Quarter 2023 Financial Results and Recent Business HighlightsAugust 11, 2023 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: HCW Biologics (HCWB) and Arrowhead Pharmaceuticals (ARWR)August 11, 2023 | finance.yahoo.comHCW Biologics Reports Second Quarter 2023 Financial Results and Recent Business HighlightsJuly 7, 2023 | finance.yahoo.comThe past year for HCW Biologics (NASDAQ:HCWB) investors has not been profitableJuly 1, 2023 | finance.yahoo.comHCWB - HCW Biologics Inc.June 16, 2023 | benzinga.comDirector at HCW Biologics Acquires Company Stock Options Worth 12,500 SharesJune 14, 2023 | baystreet.caHCW Gains on Patent NewsJune 14, 2023 | technews.tmcnet.comHCW Biologics is Granted Third Fundamental Patent: U.S. Patent for Methods of Treating Age-Related DisordersJune 14, 2023 | finance.yahoo.comHCW Biologics is Granted Third Fundamental Patent: U.S. Patent for Methods of Treating Age-Related DisordersJune 9, 2023 | benzinga.comChief Financial Officer of HCW Biologics Purchased $51K In StockJune 8, 2023 | benzinga.comHCW Biologics Chief Financial Officer Trades Company's StockMay 10, 2023 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Syros Pharmaceuticals (SYRS) and HCW Biologics (HCWB)May 10, 2023 | finance.yahoo.comHCW Biologics First Quarter 2023 Earnings: US$0.14 loss per share (vs US$0.057 loss in 1Q 2022)May 9, 2023 | marketwatch.com10-Q: HCW BIOLOGICS INC.May 9, 2023 | msn.comRecap: HCW Biologics Q1 EarningsMay 9, 2023 | msn.comHCW Biologics: Q1 Earnings InsightsMay 9, 2023 | finanznachrichten.deHCW Biologics, Inc: HCW Biologics Reports First Quarter 2023 Financial Results And Recent Business HighlightsMay 9, 2023 | finance.yahoo.comHCW Biologics Reports First Quarter 2023 Financial Results And Recent Business HighlightsApril 27, 2023 | finance.yahoo.comHCW Biologics Secures $26.25 Million Non-Dilutive Financing With Asset-Backed Development LoanApril 19, 2023 | msn.comEF Hutton Reiterates HCW Biologics (HCWB) Buy RecommendationApril 13, 2023 | finance.yahoo.comHCW Biologics Poster Presentation at AACR Annual Meeting 2023April 5, 2023 | finanznachrichten.deHCW Biologics, Inc: A Novel Immunotherapeutic Approach to Treating Aging-Associated DiseasesApril 5, 2023 | markets.businessinsider.comMaxim Group Remains a Buy on HCW Biologics (HCWB) Get HCW Biologics News Delivered to You Automatically Sign up to receive the latest news and ratings for HCWB and its competitors with MarketBeat's FREE daily newsletter. Email Address Don't Pay a Dime for Marc Lichtenfeld's Top AI Picks (Ad)Usually, you'd have to plunk down a hefty sum to get your hands on Marc Lichtenfeld's latest income research... But today, the author of Get Rich with Dividends is feeling extra generous... Click here now to claim your FREE copy of Marc's AI playbook. HCWB Media Mentions By Week HCWB Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. HCWB News Sentiment▼1.440.61▲Average Medical News Sentiment HCWB News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. HCWB Articles This Week▼20▲HCWB Articles Average Week Get HCW Biologics News Delivered to You Automatically Sign up to receive the latest news and ratings for HCWB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Enlivex Therapeutics News Today T2 Biosystems News Today AlloVir News Today CASI Pharmaceuticals News Today BioAtla News Today LifeVantage News Today PMV Pharmaceuticals News Today BeyondSpring News Today Kronos Bio News Today Instil Bio News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:HCWB) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredNext opportunity for crypto millionsThe Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has...Crypto 101 Media | Sponsoredtop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligen...Traders Agency | SponsoredThe #1 Crypto for 2024 (3 Cent Coin)Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredAlex's "Next Magnificent Seven" StocksToday Alex Green is releasing his new breakdown of AI's "Next Magnificent Seven." So please make some time ...The Oxford Club | SponsoredThe asset beating inflation by 4xCentral Bank Gold Heist In Progress Central banks are buying gold at record rates... and billionaire invest...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding HCW Biologics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share HCW Biologics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.